MentionFox
Home › Who owns › Bluejay Diagnostics, Inc.
Owners, funding and legal record

Who owns Bluejay Diagnostics, Inc.? Owners, funding and legal record

Before you sign with, sell to or invest in Bluejay Diagnostics, Inc.

MentionFox check on Bluejay Diagnostics, Inc.: no red flags found in 12 sources (checked 6 November 2026). mentionfox.com/c/who-owns/bluejay-diagnostics

Check Bluejay Diagnostics, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Bluejay Diagnostics, Inc.?

Bluejay Diagnostics, Inc. is a publicly traded company (Nasdaq: BJDX). The most recent 5%+ ownership report names Armistice Capital holding 9.99% (Schedule 13G, filed 2026-08-14).

As of November 6, 2026, Bluejay Diagnostics, Inc. is a publicly traded company (Nasdaq: BJDX); its largest reported holder is Armistice Capital, with 9.99% on Schedule 13G of August 14, 2026, then Ayrton Capital LLC (9.99%). The largest insider holding is HRT Financial LP, a 10% owner, with 92,055 shares (2.1% of shares outstanding), per Form 4 of July 13, 2026 (Schedule 13G, August 14, 2026).

Northstrive Fund II LP also filed stake reports on 2 other companies ↓

Is this your company?

About to sign with, pay or invest in Bluejay Diagnostics, Inc.? See the free Snapshot first.

Watch Bluejay Diagnostics, Inc.

Free to see. No signup.

Is Bluejay Diagnostics, Inc. a real, registered company?

Before you sign or pay

Who are Bluejay Diagnostics, Inc.'s owners and officers?

Bluejay Diagnostics, Inc.: incorporated in Delaware; business address in Acton, Massachusetts; industry Surgical & Medical Instruments & Apparatus (Schedule 13G, 2026-08-14).

ReportHolderShare
Schedule 13G, 2026-08-14Armistice Capital, LLC9.99%
Schedule 13G, 2026-08-13Ayrton Capital LLC9.99%
Schedule 13G, 2026-06-05Mitchell P. Kopin9.99%
Schedule 13D/A, 2026-06-02Braeden Lichti0%
Schedule 13D/A, 2026-06-02Northstrive Fund Ii LP0%
Schedule 13G/A, 2026-05-15Armistice Capital, LLC4.99%
Schedule 13D, 2026-03-11Northstrive Fund Ii LP3.65%
Schedule 13D, 2026-03-11Northstrive Fund Ii LP3.65%
Schedule 13D, 2026-03-11Braeden Lichti3.65%
Schedule 13G, 2026-02-18Armistice Capital, LLC9.99%
Schedule 13G, 2026-02-17Armistice Capital, LLC9.99%
Schedule 13G/A, 2026-02-13Mitchell P. Kopin4.99%

Questions about who owns Bluejay Diagnostics, Inc.

Who owns Bluejay Diagnostics, Inc.?

On this page, 3 holders' latest ownership filings report 5% or more of Bluejay Diagnostics, Inc.: Armistice Capital, LLC (9.99%, Schedule 13G, filed 2026-08-14), Ayrton Capital LLC (9.99%, Schedule 13G, filed 2026-08-13) and Mitchell P. Kopin (9.99%, Schedule 13G, filed 2026-06-05).

Who are the largest shareholders of Bluejay Diagnostics, Inc.?

By the share each holder's latest filing reports, the largest holders of Bluejay Diagnostics, Inc. on this page are Armistice Capital, LLC (9.99%), Ayrton Capital LLC (9.99%) and Mitchell P. Kopin (9.99%).

When did Armistice Capital, LLC buy into Bluejay Diagnostics, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Armistice Capital, LLC on this page is the Schedule 13G, filed 2026-02-17, reporting 9.99%; its latest, Schedule 13G filed 2026-08-14, reports 9.99%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Bluejay Diagnostics, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Bluejay Diagnostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Bluejay Diagnostics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    18 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Bluejay Diagnostics, Inc. shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares outstanding: 4,468,051 as of 2026-08-07, from the company's latest SEC cover page.

How much has Bluejay Diagnostics, Inc. raised?

No fundraising or offering filing from Bluejay Diagnostics, Inc. is on file with us.

Keep reading

More on Bluejay Diagnostics, Inc. and the records around it.

Bluejay Diagnostics, Inc. elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/bluejay-diagnostics
Last updated 2026-11-06
Primary record: Schedule 13G, 2026-08-14
Who owns Bluejay Diagnostics? Publicly traded (Nasdaq: BJDX). MentionFox, 2026-11-06. https://mentionfox.com/who-owns/bluejay-diagnostics